Agilent Technologies at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
Agilent Technologies takes part in 2 sessions at TIDES Europe 2026 in Amsterdam, and exhibits at Booth 317. Its program centres on analytics for both modalities, validating oligonucleotide methods across the product lifecycle and building integrated workflows for synthetic peptide development. The peptide workflow runs from separating peptides to confirming their sequence.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Agilent Technologies Santa Clara, CA | |
Makes liquid chromatography, mass spectrometry and other analytical instruments, and manufactures oligonucleotide active pharmaceutical ingredients under contract. | Booth Exhibiting at Booth 317 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 16:45–17:15 Analytical Method Validation Across the Oligonucleotide Lifecycle How a contract manufacturer validates the tests used to check oligonucleotide drugs, from raw materials to release, without slowing development. Talk Wed Nov 4 11:50–12:20 Integrated Analytical Workflows for Synthetic Peptide Development: From Peptide Separation to Sequence Confirmation Combining separation, mass measurement and software to confirm a synthetic peptide's sequence, purity and starting materials at every stage. PeptidesCMC & Manufacturing |
Instantly find 20 buyers from Agilent Technologies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction